Currently predicting for Thu, 4 Jun 2026

CGEN Prediction Chart

CGEN Predictions History

Latest community submissions for CGEN.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 15, 2024 $2.17 +1.76% $1.96 X 89.41% 0
Apr 15, 2024 Bullish $1.96 X 0
JS JS Pro
Feb 1, 2024 $2.37 -1.66% $2.42 X 97.93% 0
Feb 1, 2024 $2.33 -3.21% $2.42 X 96.39% 0
Feb 1, 2024 $2.36 -2.01% $2.42 X 97.59% 0
Jul 5, 2023 $1.11 -3.31% $1.15 X 96.69% 0
Jul 5, 2023 $1.13 -2.07% $1.15 X 97.93% 0
BullishBunny89 BullishBunny89 Amateur
Jul 5, 2023 Bullish $1.15 X 0
JS JS Pro
Oct 24, 2022 $0.81 -1.93% $0.80 V 98.25% 1
Oct 24, 2022 $0.88 +5.72% $0.80 X 90.31% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CGEN with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT COMPUGEN LTD.
Compugen
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I clinical study in patients wi...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE